Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Rajkumar

Showing results (281-290 of 773) with videos related to

Pageof 78
Sort By:
Blood|July 26, 2003
Long-term follow-up of IgM monoclonal gammopathy of undetermined significanceRobert A Kyle, Terry M Therneau, S Vincent Rajkumar, et al.
Mayo Clinic Proceedings|April 17, 2018
Fifty-Year Incidence of Waldenström Macroglobulinemia in Olmsted County, Minnesota, From 1961 Through 2010: A Population-Based Study With Complete Case Capture and Hematopathologic ReviewRobert A Kyle, Dirk R Larson, Ellen D McPhail, et al.
Cancer|February 14, 2006
Extended follow-up of a phase II trial in relapsed, refractory multiple myeloma:: final time-to-event results from the SUMMIT trialPaul G Richardson, Bart Barlogie, James Berenson, et al.
Archives of Dermatology|October 19, 2005
Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantationMartha Q Lacy, William J Hogan, Morie A Gertz, et al.
Blood|April 24, 2009
Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health StudyOla Landgren, Robert A Kyle, Jane A Hoppin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2008
Multicenter, randomized, double-blind, placebo-controlled study of thalidomide plus dexamethasone compared with dexamethasone as initial therapy for newly diagnosed multiple myelomaS Vincent Rajkumar, Laura Rosiñol, Mohamad Hussein, et al.
British Journal of Haematology|October 9, 2003
Plasma levels of tumour necrosis factor alpha and interleukin-6 predict progression-free survival following thalidomide therapy in patients with previously untreated multiple myelomaMichael A Thompson, Thomas E Witzig, Shaji Kumar, et al.
European Journal of Haematology|May 19, 2010
Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myelomaFrancesca Gay, S Vincent Rajkumar, Patrizia Falco, et al.
Clinical Chemistry|December 3, 2014
Monitoring IgA multiple myeloma: immunoglobulin heavy/light chain assaysJerry A Katzmann, Maria A V Willrich, Mindy C Kohlhagen, et al.
Blood Cancer Journal|September 2, 2022
Comparison of two free light chain assays: performance of the involved free light chain ratio and implications for diagnosis of multiple myelomaMaria Alice V Willrich, David L Murray, S Vincent Rajkumar, et al.
Pageof 78

Showing results (281-290 of 773) with videos related to

Sort By:
Pageof 78
Blood|July 26, 2003
Long-term follow-up of IgM monoclonal gammopathy of undetermined significanceRobert A Kyle, Terry M Therneau, S Vincent Rajkumar, et al.
Mayo Clinic Proceedings|April 17, 2018
Fifty-Year Incidence of Waldenström Macroglobulinemia in Olmsted County, Minnesota, From 1961 Through 2010: A Population-Based Study With Complete Case Capture and Hematopathologic ReviewRobert A Kyle, Dirk R Larson, Ellen D McPhail, et al.
Cancer|February 14, 2006
Extended follow-up of a phase II trial in relapsed, refractory multiple myeloma:: final time-to-event results from the SUMMIT trialPaul G Richardson, Bart Barlogie, James Berenson, et al.
Archives of Dermatology|October 19, 2005
Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantationMartha Q Lacy, William J Hogan, Morie A Gertz, et al.
Blood|April 24, 2009
Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health StudyOla Landgren, Robert A Kyle, Jane A Hoppin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2008
Multicenter, randomized, double-blind, placebo-controlled study of thalidomide plus dexamethasone compared with dexamethasone as initial therapy for newly diagnosed multiple myelomaS Vincent Rajkumar, Laura Rosiñol, Mohamad Hussein, et al.
British Journal of Haematology|October 9, 2003
Plasma levels of tumour necrosis factor alpha and interleukin-6 predict progression-free survival following thalidomide therapy in patients with previously untreated multiple myelomaMichael A Thompson, Thomas E Witzig, Shaji Kumar, et al.
European Journal of Haematology|May 19, 2010
Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myelomaFrancesca Gay, S Vincent Rajkumar, Patrizia Falco, et al.
Clinical Chemistry|December 3, 2014
Monitoring IgA multiple myeloma: immunoglobulin heavy/light chain assaysJerry A Katzmann, Maria A V Willrich, Mindy C Kohlhagen, et al.
Blood Cancer Journal|September 2, 2022
Comparison of two free light chain assays: performance of the involved free light chain ratio and implications for diagnosis of multiple myelomaMaria Alice V Willrich, David L Murray, S Vincent Rajkumar, et al.
Pageof 78